The production of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, involves a complex several-stage synthetic process. Preliminary routes focused on amino acid chain fragment coupling, https://nicolasbdwt809868.blogadvize.com/49158965/synthesis-and-investigation-uses-of-retatrutide